Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $718.77 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $403.62 | 7 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $125.00 | 1 | $0 (2022) |
| Corcept Therapeutics | $107.92 | 1 | $0 (2023) |
| Amarin Pharma Inc. | $55.56 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $15.00 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.67 | 1 | Novo Nordisk Inc ($116.67) |
| 2023 | $124.42 | 2 | Corcept Therapeutics ($107.92) |
| 2022 | $343.48 | 3 | Novo Nordisk Inc ($218.48) |
| 2021 | $12.44 | 1 | Amarin Pharma Inc. ($12.44) |
| 2020 | $43.12 | 3 | Amarin Pharma Inc. ($43.12) |
| 2018 | $26.67 | 2 | AstraZeneca Pharmaceuticals LP ($15.00) |
| 2017 | $51.97 | 3 | Novo Nordisk Inc ($51.97) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: Obesity | ||||||
| 03/26/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $107.92 | General |
| Category: Endocrinology | ||||||
| 01/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 11/01/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $101.29 | General |
| Category: Obesity | ||||||
| 06/30/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $117.19 | General |
| Category: Diabetes | ||||||
| 05/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 06/04/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Cardiovascular | ||||||
| 12/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiovascular | ||||||
| 10/13/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Cardiovascular | ||||||
| 07/14/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular | ||||||
| 09/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/03/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuroscience | ||||||
| 04/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 03/30/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 02/14/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 116 | 164 | $67,146 | $15,518 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 48 | 75 | $29,925 | $6,939 | 23.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 21 | $16,317 | $3,766 | 23.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 35 | 54 | $15,066 | $3,467 | 23.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 13 | 14 | $5,838 | $1,347 | 23.1% |
About Dr. Yue He Wang, MD
Dr. Yue He Wang, MD is a Family Medicine healthcare provider based in Raritan, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669549903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yue He Wang, MD has received a total of $718.77 in payments from pharmaceutical and medical device companies, with $116.67 received in 2024. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($718.77).
As a Medicare-enrolled provider, Wang has provided services to 116 Medicare beneficiaries, totaling 164 services with total Medicare billing of $15,518. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Raritan, NJ
- Active Since 11/30/2006
- Last Updated 09/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669549903
Products in Payments
- Wegovy (Drug) $217.96
- Kerendia (Drug) $125.00
- Ozempic (Drug) $117.19
- Korlym (Drug) $107.92
- Vascepa (Drug) $55.56
- Victoza (Drug) $51.97
- Rybelsus (Drug) $16.50
- MOVANTIK (Drug) $15.00
- Trintellix (Drug) $11.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.